We are live on ! Find out more
USNA icon

Usana Health Sciences

145 hedge funds and large institutions have $581M invested in Usana Health Sciences in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 11

38% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 40

12% more funds holding

Funds holding: 130145 (+15)

7.69% more ownership

Funds ownership: 103.28%110.97% (+7.7%)

7% more capital invested

Capital invested by funds: $542M → $581M (+$39.2M)

Holders
145
Holders Change
+15
Holders Change %
+11.54%
% of All Funds
4.19%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
55
Reduced
40
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$122M +$1.75M +50,084 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$49.3M +$5.12M +146,566 +13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$38M +$496K +14,200 +1%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$26.6M -$224K -6,404 -0.9%
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$26.5M -$736K -21,070 -3%
LSV Asset Management
6
LSV Asset Management
Illinois
$25.8M +$194K +5,566 +0.8%
BIT
7
BlackRock Institutional Trust
California
$19.7M -$1.14M -32,680 -6%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$14.2M -$90K -2,576 -0.7%
BFA
9
BlackRock Fund Advisors
California
$11.4M +$238K +6,814 +2%
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$11.2M +$3.2M +91,674 +45%
Northern Trust
11
Northern Trust
Illinois
$10.4M +$2.67M +76,496 +38%
JP Morgan Chase
12
JP Morgan Chase
New York
$10M +$828K +23,694 +10%
Morgan Stanley
13
Morgan Stanley
New York
$8.9M +$2.76M +78,952 +50%
WA
14
Wasatch Advisors
Utah
$7.99M +$521K +14,918 +8%
State Street
15
State Street
Massachusetts
$7.96M -$221K -6,328 -3%
Deutsche Bank
16
Deutsche Bank
Germany
$7.8M +$1.52M +43,660 +27%
AQR Capital Management
17
AQR Capital Management
Connecticut
$7.27M +$21K +600 +0.3%
JIR
18
James Investment Research
Ohio
$7.11M -$1.69M -48,270 -20%
Goldman Sachs
19
Goldman Sachs
New York
$6.67M -$1.14M -32,740 -16%
NI
20
Numeric Investors
Massachusetts
$5.99M +$3.78M +108,218 +213%
TA
21
Teachers Advisors
New York
$5.82M +$4.78M +136,980 +778%
American Century Companies
22
American Century Companies
Missouri
$5.56M -$1.29M -36,824 -20%
Norges Bank
23
Norges Bank
Norway
$5.52M
QBFM
24
QS Batterymarch Financial Management
New York
$4.99M +$6.99K +200 +0.2%
ARC
25
Absolute Return Capital
Massachusetts
$4.97M -$352K -10,088 -7%

USNA Hedge Fund Activity: Q1 2014 in Review

145 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2014, worth a combined $581M — up 7.2% from $542M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new USNA positions and 11 closed out — a net gain of 16 holders — while 55 added to existing stakes and 40 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $5.12M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $3.54M sold.

  • 145 institutional investors held Usana Health Sciences (USNA) as of Q1 2014, up from 130 in Q4 2013.
  • Funds reported $581M of Usana Health Sciences stock for Q1 2014, up 7.2% quarter-over-quarter.
  • 27 funds opened new Usana Health Sciences positions in Q1 2014 and 11 closed out, a net change of +16 holders.
  • The largest Usana Health Sciences buyer in Q1 2014 was Renaissance Technologies, an estimated $5.12M added.
  • The largest Usana Health Sciences seller in Q1 2014 was Oxford Asset Management, an estimated $3.54M sold.

Based on aggregated 13F filings for Q1 2014.